Autonomic Nervous System Reactivity of the Newborn After a Nociceptive Stress: Interest of Sucrose and Non-nutritive Sucking (BBSUCROSE)

Autonomic Nervous System Reactivity of the Newborn After a Nociceptive Stress: Interest of Sucrose and Non-nutritive Sucking : A Controlled Randomized Single-center Study.

The management of the pain is a constant care concern in neonatal and maternity units. Many studies show an interest in the use of sugar solutions to reduce nociception during painful events in infants. However, these studies are based mainly on behavioral observation of the newborn but intrinsic mechanisms of analgesic power are not clearly understood for sucrose solutions.

Our hypothesis is that the analgesic mechanism of sucrose solutions in infants involves a subcortical reactivity notably by action via the brain stem. To explore the intensity of pain and evaluate the subcortical activity, we will use 1) the analysis of heart rate variability (frequency indices whose HFnu) as a peripheral witness of subcortical functioning of the autonomic nervous system 2) electroacoustic analysis of the intensity of crying baby, 3) a composite pain score (DAN score).

Study Overview

Detailed Description

The investigators want to show that the short term autonomic nervous system (ANS) response, after a nociceptive action in the new-born in maternity depends on whether it is preceded by non-nutritive sucking and / or sucrose administration.

Study Type

Interventional

Enrollment (Actual)

180

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Saint-etienne, France, 42000
        • Chu de Saint-Etienne

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 1 week (Child)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Healthy Newborn in maternity unit of the Saint-Etienne University Hospital (France), to receive venipuncture for blood tests or neonatal screening test
  • Establishing consent form signed by the holder of parental authority

Exclusion Criteria:

  • Children suffering from a disease affecting the central nervous system.
  • Children treated with paracetamol oral solution (if cephalohematoma for example) or other analgesics (nalbuphine) or sedative, at the time of registration.
  • Newborns impregnated with a prepartum maternal analgesia.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Glucose sucking

The newborn will receive one minute before the painful care either a compress with sucrose.

The puncture made in the veins of the back of the hand, will be performed only once per patient per test.

Glucose 30% by oral route (1 ml).

Other Names:
  • Glucose PROAMP 30%, Laboratoires AGUETTANT
Active Comparator: Water sucking

The newborn will receive one minute before the painful care either a compress with water.

The puncture made in the veins of the back of the hand, will be performed only once per patient per test.

Sterile water by oral route (1 ml).

Other Names:
  • Eau ppi, BRAUN
Placebo Comparator: No sucking
The puncture made in the veins of the back of the hand, will be performed only once per patient per test.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
High frequency normalized index (HFnu)
Time Frame: From 15 min before the painful care to 15 min after.
It is a reflect of the RR short term heart rate variability (HRV) in the frequency domain. It is measured with a ECG Holter monitor.
From 15 min before the painful care to 15 min after.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Low frequency (LF and LFnu),
Time Frame: From 15 min before the painful care to 15 min after.
It is another index of RR heart rate variability (HRV) measured with a ECG Holter monitor.
From 15 min before the painful care to 15 min after.
Scale of hetero-assessment of pain (DAN)
Time Frame: 15 minutes after the painful care
The DAN scale is specific to acute pain of the newborn
15 minutes after the painful care
Electro acoustical characteristic of crying newborn : Duration
Time Frame: From 15 min before the painful care to 15 min after.
An acoustic recording of children's tears will be conducted in parallel with a microphone and dedicated software to study the properties of crying caused by the puncture. Continuous recording begins at least fifteen minutes before the procedure and is kept up to fifteen minutes after the invasive procedure. The child must be quiet. It will be placed in its cocoon to limit environmental stress
From 15 min before the painful care to 15 min after.
Frequency domain
Time Frame: From 15 min before the painful care to 15 min after.
It is another index of RR heart rate variability (HRV) measured with a ECG Holter monitor.
From 15 min before the painful care to 15 min after.
The time domain (SDNN, SDANN, pNN50).
Time Frame: From 15 min before the painful care to 15 min after.
It is another index of RR heart rate variability (HRV) measured with a ECG Holter monitor.
From 15 min before the painful care to 15 min after.
LF / HF ratio
Time Frame: From 15 min before the painful care to 15 min after.
It is another index of RR heart rate variability (HRV) measured with a ECG Holter monitor.
From 15 min before the painful care to 15 min after.
Electro acoustical characteristic of crying newborn : Frequency
Time Frame: From 15 min before the painful care to 15 min after.
An acoustic recording of children's tears will be conducted in parallel with a microphone and dedicated software to study the properties of crying caused by the puncture. Continuous recording begins at least fifteen minutes before the procedure and is kept up to fifteen minutes after the invasive procedure. The child must be quiet. It will be placed in its cocoon to limit environmental stress
From 15 min before the painful care to 15 min after.
Electro acoustical characteristic of crying newborn : Frequency variations
Time Frame: From 15 min before the painful care to 15 min after.
An acoustic recording of children's tears will be conducted in parallel with a microphone and dedicated software to study the properties of crying caused by the puncture. Continuous recording begins at least fifteen minutes before the procedure and is kept up to fifteen minutes after the invasive procedure. The child must be quiet. It will be placed in its cocoon to limit environmental stress
From 15 min before the painful care to 15 min after.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hugues PATURAL, MD PhD, Chu de Saint-Etienne

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2014

Primary Completion (Actual)

April 1, 2015

Study Completion (Actual)

April 1, 2015

Study Registration Dates

First Submitted

February 10, 2015

First Submitted That Met QC Criteria

February 23, 2015

First Posted (Estimate)

February 27, 2015

Study Record Updates

Last Update Posted (Estimate)

March 30, 2016

Last Update Submitted That Met QC Criteria

March 29, 2016

Last Verified

March 1, 2016

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Newborn

Clinical Trials on Glucose sucking

Subscribe